KRAS/NRAS Gene Mutations and the Efficacy of Bortezomib-Based Triplet Induction Therapy in Patients with Newly Diagnosed Multiple MyelomaAnna Sergeeva, Л. П. Менделеева, M. V. Solovev et al.|Clinical oncohematology|2024Cited by 1
Early and late relapses of multiple myeloma after autologous haematopoietic stem cell transplantationE. A. Mamaeva, Larisa A. Kuzmina, Л. П. Менделеева et al.|Гематология и трансфузиология|2021Cited by 0